Authors: Carducci, MA Gilbert, J Bowling, MK Noe, D Eisenberger, MA Sinibaldi, V Zabelina, Y Chen, TL Grochow, LB Donehower, RC

Citation: Ma. Carducci et al., A phase I clinical and pharmacological evaluation of sodium phenylbutyrateon an 120-h infusion schedule, CLIN CANC R, 7(10), 2001, pp. 3047-3055

Authors: Bubley, GJ Carducci, M Dahut, W Dawson, N Daliani, D Eisenberger, M Figg, WD Freidlin, B Halabi, S Hudes, G Hussain, M Kaplan, R Myers, C Oh, W Petrylak, DP Reed, E Roth, B Sartor, O Scher, H Simons, J Sinibaldi, V Small, EJ Smith, MR Trump, DL Vollmer, R Wilding, G

Citation: Gj. Bubley et al., Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: Recommendations from the prostate-specific antigen working group, J CL ONCOL, 17(11), 1999, pp. 3461-3467